Linda M. Arterburn, PhD

Linda M. Arterburn, PhD has extensive work experience in various roles related to regulatory affairs, scientific and clinical affairs, and drug development. Linda M. currently holds the position of Vice President Regulatory Affairs at Provention Bio, starting in July 2020. Prior to this, they worked at Medifast, Inc. / Jason Pharmaceuticals as the Vice President, Scientific and Clinical Affairs from July 2013 to July 2020. Linda also served as the Director, Regulatory Affairs at the International Partnership for Microbicides from February 2011 to July 2013. Linda M. worked as a Principal at Sedulus BioDevelopment from September 2010 to July 2013 and as the Vice President, Drug Development at Alba Therapeutics from March 2007 to June 2010. Earlier in their career, Linda held various positions at Martek Biosciences, including Executive Director, Discovery Research from 2004 to 2007 and Senior Director, Clinical Research from 1997 to 2004. Linda M. began their professional journey at WR Grace as the Manager, Technology and Planning from 1990 to 1997.

Linda M. Arterburn, PhD completed their Bachelor of Science (B.S.) degree in Biochemistry from the University of Wisconsin-Madison between 1980 and 1984. Following that, they pursued higher education at The Johns Hopkins University School of Medicine, where they obtained their PhD in Pharmacology and The Molecular Sciences from 1985 to 1990. Moreover, Linda M. Arterburn also engaged in a graduate program at the University of Maryland Baltimore County, specializing in ACTiVATE in 2011.